General Updates

Date: 27th August, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol: SURAKSHA Dear Sir / Ma’am, Sub: Intimation under Regulation 30 and 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter to those Members whose e- mail addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA), i.e. KFin Technologies Limited/Depository Participants (DPs)/Depositories is being dispatched by the Company. This intimation is also being made available on the website of the Company i.e. www.surakshanet.com. A specimen copy of the dispatched letter is enclosed herewith. Kindly take the same on record.. Thank you. Yours Faithfully, For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Encl.: as above Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 Date: 27th August, 2026 Dear Shareholder, Sub: Details regarding 21st Annual General Meeting of the Members of Suraksha Diagnostic Limited and Annual Report for the Financial Year 2025-26. We are pleased to inform you that the 21st Annual General Meeting (‘AGM’) of Suraksha Diagnostic Limited (‘the Company’) is scheduled to be held on Tuesday, 22 September, 2026, at 11:30 A.M. (IST) through Video Conference (“VC”) / Other Audio Visual Means (“OAVM”). In compliance with Regulation 36(1)(b) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“SEBI Listing Regulations, 2015”), you can access the Annual Report along with the notice of the AGM through the following weblink https://www.surakshanet.com/annual- report.php. The path for the Annual Report is www.surakshanet.com>>Investors>>Annual Report>> Suraksha Annual Report FY 2025-26. Additionally, the Annual Report along with the notice of the AGM are also available on the website of the Stock Exchanges where the securities of the Company are listed, i.e., BSE Limited and The National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com, respectively, and on the website of NSDL at www.evoting.nsdl.com and on the website of KFIN Technologies Limited (Registrar and Transfer Agent of the Company). Key Details of the AGM: Particulars Details Record Date for Dividend Tuesday, 15 September, 2026 Cut-off Date for e-voting Tuesday, 15 September, 2026 Remote e-voting period Friday, 18 September, 2026 at 9:00 A.M. (IST) to Monday, 21 September, 2026 at 5:00 P.M. (IST) In compliance with Regulation 36(1)(a) of SEBI Listing Regulations, 2015, soft copy of the Annual Report for Financial Year 2025-26 which includes the Notice convening the AGM is being sent through email to all those shareholder(s) whose e-mail address are registered with the Company / Depositories. In case, your KYC details are not yet registered pertaining to the name, postal address, E-mail address, telephone/mobile numbers, Permanent Account Number (PAN), nominations, power of attorney, bank details such as name of the bank and branch details, bank account number, MICR code, IFSC code, etc., members are requested to update the details with their respective Depository Participants. In case, you have any queries or need any information/clarification, please write to or contact our RTA at KFIN Technologies Limited, Selenium Tower B, Plot Nos. 31 & 32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad – 500032, India, E-mail Id: einward.ris@kfintech.com. Thanking you, Yours faithfully, For Suraksha Diagnostic Limited Sd/- Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750